Piramal Pharma gains 8% as co aims for $2 billion revenue by …
WEBSeptember 25, 2024 / 09:58 IST. Piramal Pharma Ltd. Shares of Piramal Pharma rose over 8 percent on September 25 after the company outlined its ambitious roadmap at a recent analyst meeting ...
Piramal Pharma shares gain 2% after EIR from USFDA for
WEB3 days ago — September 30, 2024 / 09:23 IST. Piramal Pharma. Piramal Pharma share price jumps 2 percent in the opening trade on September 30 after the company received Establishment Inspection Report (EIR) for ...
Piramal Pharma targets to double revenue in 5 years
WEBSep 25, 2024 — Mumbai: Piramal Pharma has set itself a target of reaching $2 billion in annual revenue with a 25% operating margin by fiscal 2030, largely led by its contract development and manufacturing organisation (CDMO) business. The Mumbai-based company is hoping to double its CDMO revenue by FY30. Piramal Pharma posted ₹8,171 crore ($987 million) of revenue in FY24, with CDMO contributing ₹4,750 ...
Piramal Pharma Share Price Today (30 Sep, 2024), Piramal Pharma …
WEB2 days ago — Check out why Piramal Pharma share price is up today. Get all details on Piramal Pharma Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Piramal Pharma hits record high in weak market; surges 12% on …
WEBSep 4, 2024 — Piramal Pharma share price today: Shares of Piramal Pharma (PPL) hit a record high of Rs 216.58, surging 12 per cent on the National Stock Exchange (NSE), in Wednesday's intraday amid heavy volumes.
Piramal Pharma Q1FY25 results; Loss improves to Rs 89 cr; shares …
WEBJul 26, 2024 — Shares of Piramal Pharma rose 3.51 per cent, reaching their 52-week high at Rs 172.10 per share on the BSE in Friday'’s intraday trade. The stock movement comes after the company reported its first quarter earnings for …
Piramal Pharma share price rises over 7% to hit 18-month high.
WEBPiramal Pharma share price: Shares of Piramal Pharma jumped 7.35% in today's trading session to reach a new 52-week high of ₹ 153.90 apiece. With this, the stock reached its highest level...
Piramal Pharma Limited Announces Consolidated Results for Q3 …
WEBMUMBAI, India, Jan. 30, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated...
Piramal Pharma Limited Announces Consolidated Results for Q3 …
WEBJan 30, 2024 — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Months...
Piramal Pharma Limited Announces Consolidated Results for Q2 …
WEBMUMBAI, India, Oct. 28, 2023 /PRNewswire/ -- Piramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results...